Igc PharmaIGC
13F holders, Q3 2024 (September 30)23holders −2
2new positions
4sold out
$0.43avg. 13F price*
At the end of Q3 2024, 23 institutions reported holding Igc Pharma Inc. (IGC) in their 13F filings, down 2 from Q2 2024. 2 opened new positions and 4 sold out. The largest holders were BlackRock, Inc. ($300K), Vanguard Group Inc. ($275K) and Geode Capital Management, LLC ($240K).
- Company
- Igc Pharma Inc.
- CUSIP
- 45408X308
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $45K |
| Exits | 4 | $76K |
All 13F filers, Q2 2024 → Q3 2024: 418,785 shares bought and 176,186 shares sold, net +242,599 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 23 holders
| BlackRock, Inc. | 0.00% | — | 703,798 | $300K |
| Vanguard Group Inc. | 0.00% | No change | 645,166 | $275K |
| Geode Capital Management, LLC | 0.00% | Add +31.0% | 562,969 | $240K |
| State Street Corp. | 0.00% | No change | 165,307 | $71K |
| Virtu Financial LLC | 0.00% | Add +164.7% | 123,060 | $53K |
| Dearborn Partners LLC | 0.00% | No change | 116,401 | $50K |
| Two Sigma Securities, LLC | 0.00% | Add +194.7% | 99,017 | $42K |
| Fullcircle Wealth LLC | 0.02% | New | 103,443 | $42K |
| Northern Trust Corp. | 0.00% | No change | 71,027 | $30K |
| Goldman Sachs Group Inc. | 0.00% | Add +0.1% | 65,541 | $28K |
| Commonwealth Equity Services, LLC | 0.00% | Add +28.9% | 44,600 | $19K |
| Truist Financial Corp. | 0.00% | No change | 36,667 | $16K |
| Group One Trading LLC | 0.00% | Reduce -3.2% | 21,409 | $9K |
| Morgan Stanley | 0.00% | Add +1964.8% | 17,757 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +30.9% | 10,496 | $4K |
| Baader Bank Aktiengesellschaft | 0.00% | New | 10,533 | $3K |
| Geneos Wealth Management Inc. | 0.00% | No change | 3,000 | $1K |
| Osaic Holdings, Inc. | 0.00% | Add +15.6% | 925 | $397 |
| CIBC Private Wealth Group LLC | 0.00% | No change | 655 | $280 |
| Bank of America Corp. | 0.00% | Add +35.0% | 563 | $240 |
| Caitlin John, LLC | 0.00% | No change | 200 | $73 |
| DHJJ Financial Advisors, Ltd. | 0.00% | No change | 80 | $35 |
| Simplex Trading, LLC | 0.00% | Reduce -49.7% | 1,012 | $0 |
"% of holder's portfolio" is IGC's weight in each manager's 13F, not the share of Igc Pharma Inc. the manager owns.